A Phase 1 Study of KH902, a Vascular Endothelial Growth Factor Receptor Decoy, for Exudative Age-Related Macular Degeneration

Ranibizumab for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al. · New England Journal of Medicine · 2006 · 5.9K citations · Full text

Medicine, Ophthalmology, Surgery +12

Prevalence of Age-Related Macular Degeneration in the United States

Archives of Ophthalmology · 2004 · 2.7K citations · Full text

Medicine, Ophthalmology, Population Health Sciences +15

Pegaptanib for Neovascular Age-Related Macular Degeneration

Evangelos S. Gragoudas, Anthony P. Adamis, Emmett T. Cunningham et al. · New England Journal of Medicine · 2004 · 2.3K citations · Full text

Medicine, Ophthalmology, Pharmacology +11

VEGF-Trap: A VEGF blocker with potent antitumor effects

Jocelyn Holash, Sam Davis, Susan D. Croll et al. · Proceedings of the National Academy of Sciences · 2002 · 1.7K citations

Medicine, Oncology, Pharmacology +17

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions

Peter Carmeliet, Lieve Moons, Aernout Luttun et al. · Nature Medicine · 2001 · 1.7K citations

Medicine, Pathobiology, Tumor Microenvironment +13